Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-28T10:40:36.279Z Has data issue: false hasContentIssue false

39 - Neuropathology of Parkinson's disease

from Part VII - Parkinson's and related movement disorders

Published online by Cambridge University Press:  04 August 2010

M. Flint Beal
Affiliation:
Cornell University, New York
Anthony E. Lang
Affiliation:
University of Toronto
Albert C. Ludolph
Affiliation:
Universität Ulm, Germany
Dennis W. Dickson
Affiliation:
Departments of Neuroscience and Pathology (Neuropathology), Mayo Clinic Jacksonville, FL, USA
Get access

Summary

Introduction

The clinical features of Parkinson's disease (PD) are bradykinesia, rigidity, tremor and postural instability, but increasingly recognized are non-motor manifestations, such as anosmia, autonomic dysfunction, sleep disorders, psychiatric symptoms (e.g. depression) and cognitive impairment. The typical clinical features of PD reflect well-known pathology in the dopaminergic nigrostriatal system, while extra-nigral pathology accounts for many of the non-motor features of PD. As will be subsequently discussed, the most characteristic pathologic feature of PD is neurodegeneration with Lewy body (LB) formation, but it must be acknowledged that occasionally other pathologic processes cause clinical features typical of PD. In particular, some cases of multiple system atrophy (MSA) or even progressive supranuclear palsy (PSP) may be clinically mistaken for PD (Bower et al., 2002). More problematic are cases of PD with juvenile onset or those associated with an autosomal recessive pattern of inheritance, such as cases with Parkin and DJ-1 mutations (see below), in which LBs may not be present. Other early onset familial cases present with atypical clinical features such as early dementia and psychosis, which are not characteristic of typical PD (Gwinn-Hardy et al. 2000). Another diagnostic challenge is the relationship of cognitive dysfunction in PD to concurrent Alzheimer's disease and dementia with Lewy bodies (DLB) (McKeith et al. 1996).

As in all neurologic syndromes, the clinical presentation reflects the neuroanatomy of the disease process more than the nature of the underlying pathology.

Type
Chapter
Information
Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 575 - 585
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abe, Y., Kachi, T., Kato, T.et al. (2003). Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J. Neurol. Neurosurg., Psychiatr., 74, 419–22CrossRefGoogle ScholarPubMed
Apaydin, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F. & Dickson, D. W. (2002). Parkinson's disease neuropathology: later-developing dementia and loss of the levodopa response. Arch. Neurol., 59, 102–12CrossRefGoogle ScholarPubMed
Baba, M., Nakajo, S., Tu, P. H.et al. (1998). Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol., 152, 879–84Google ScholarPubMed
Bower, J. H., Dickson, D. W., Taylor, L., Maraganore, D. M. & Rocca, W. A. (2002). Clinical correlates of the pathology underlying parkinsonism: A population perspective. Mov. Disord., 17, 910–16CrossRefGoogle ScholarPubMed
Braak, H., Del Tredici, K., Rüb, U., Vos, R. A. I., Jansen Steur, E. N. H. & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Agin., 24, 197–211CrossRefGoogle ScholarPubMed
Churchyard, A. & Lees, A. (1997). The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology, 49, 1570–6CrossRefGoogle ScholarPubMed
Conway, K. A., Harper, J. D. & Lansbury, P. T. (1998). Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med., 4, 1318–20CrossRefGoogle ScholarPubMed
DeLucia, M. W., Cookson, N. & Dickson, D. W. (2002). Synuclein-immunoreactive Lewy bodies are detected in the amygdala in less than 20% of Alzheimer's disease (AD) cases. J. Neuropathol. Exp. Neurol., 61, 454Google Scholar
Dickson, D. W., Davies, P., Mayeux, R.et al. (1987). Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol., 75, 8–15CrossRefGoogle ScholarPubMed
Dickson, D. W. (1999). Tau and synuclein and their role in neuropathology. Brain Pathol., 9, 657–61CrossRefGoogle ScholarPubMed
Dickson, D. W. (2001). α-Synuclein and the Lewy body disorders. Curr. Opin. Neurol., 14, 423–32CrossRefGoogle ScholarPubMed
Dickson, D. W., Ruan, D., Crystal, H., Kress, Y. & Yen, S.-H. (1991). Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology, 41, 1402–9CrossRefGoogle ScholarPubMed
Dickson, D. W., Liu, W.-K., Hardy, J.et al. (1999). Widespread alterations of alpha-synuclein in multiple system atrophy. Am. J. Pathol., 155, 1241–51CrossRefGoogle ScholarPubMed
Duda, J. E., Giasson, B. I., Mabon, M. E., Lee, V. M. & Trojanowski, J. Q. (2002). Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol., 52, 205–10CrossRefGoogle ScholarPubMed
Fearnley, J. M. & Lees, A. J. (1991). Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114, 2283–301CrossRefGoogle ScholarPubMed
Galloway, P. G., Mulvihill, P. & Perry, G. (1992). Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol., 140, 809–15Google ScholarPubMed
Galvin, J. E., Lee, V. M., Baba, M.et al. (1997). Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit. Ann. Neurol., 42, 595–603CrossRefGoogle ScholarPubMed
Giasson, B. I., Forman, M. S., Higuchi, M.et al. (2003). Initiation and synergistic fibrillization of tau and alpha-synuclein. Science, 300, 636–40CrossRefGoogle ScholarPubMed
Gibb, W. R. & Lees, A. J. (1991). Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr., 54, 388–96CrossRefGoogle ScholarPubMed
Gibb, W. R. & Poewe, W. H. (1986). The centenary of Friederich H. Lewy 1885–1950. Neuropathol. Appl. Neurobiol., 12, 217–22CrossRefGoogle Scholar
Goetz, C. G., Luthe, W. & Tanner, C. M. (1986). Autonomic dysfunction in Parkinson's disease. Neurology, 36, 73–5CrossRefGoogle ScholarPubMed
Goldman, J. E., Yen, S.-H., Chiu, F.-C. & Peress, N. S. (1983). Lewy bodies of Parkinson's disease contain neurofilament antigens. Science, 221, 1082–4CrossRefGoogle ScholarPubMed
Gwinn-Hardy, K., Mehta, N. D., Farrer, M.et al. (2000). Distinctive neuropathology revealed by α-synuclein antibodies in hereditary Parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol., 99, 663–72CrossRefGoogle ScholarPubMed
Hamilton, R. L. (2000). Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol., 10, 378–84CrossRefGoogle ScholarPubMed
Hansen, L., Salmon, D., Galasko, D.et al. (1990). Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology, 40, 1–8CrossRefGoogle Scholar
Harding, A. J. & Halliday, G. M. (2001). Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol., 102, 355–63Google ScholarPubMed
Harding, A. J., Broe, G. A. & Halliday, G. M. (2002). Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain, 125, 391–403CrossRefGoogle ScholarPubMed
Hardy, J., Cookson, M. R. & Singleton, A. (2003). Genes and parkinsonism. Lancet Neurol., 2, 221–8CrossRefGoogle ScholarPubMed
Hawkes, C. H., Shepard, B. C. & Daniel, S. E. (1997). Olfactory dysfunction in Parkinson's disease. J. Neurol. Neurosurg., Psychiatr., 62, 436–46CrossRefGoogle ScholarPubMed
Hughes, A. J., Daniel, S. E., Blankson, S. & Lees, A. J. (1993). A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol., 50, 140–8CrossRefGoogle ScholarPubMed
Hughes, A. J., Daniel, S. E. & Lees, A. J. (2001). Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology, 57, 1497–9CrossRefGoogle ScholarPubMed
Hurtig, H. I., Trojanowski, J. Q., Galvin, J.et al. (2000). Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology, 54, 1916–21CrossRefGoogle ScholarPubMed
Irizarry, M. C., Growdon, W., Gomez-Isla, T.et al. (1998). Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol., 57, 334–337CrossRefGoogle ScholarPubMed
Ishizawa, T., Mattila, P., Davies, P., Wang, D. & Dickson, D. W. (2003). Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J. Neuropathol. Exp. Neurol., 62, 389–97CrossRefGoogle ScholarPubMed
Iwatsubo, T., Yamaguchi, H., Fujimuro, M.et al. (1996). Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol., 148, 1517–29Google ScholarPubMed
Jellinger, K. A. (1999). Post mortem studies in Parkinson's disease – is it possible to detect brain areas for specific symptoms?J. Neural. Transm. Suppl., 56, 1–29CrossRefGoogle ScholarPubMed
Jellinger, K. A. (2003). α-Synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution – a pilot study. Acta Neuropathol., 106, 191–201CrossRefGoogle ScholarPubMed
Jellinger, K. A. & Duda, J. (2003). Neurodegeneration with brain iron accumulation, type 1 (Hallervorden-Spatz disease). In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, ed. D. W. Dickson, pp. 394–9. Basel: ISN Neuropath Press
Jellinger, K. A. & Mizuno, Y. (2003). Parkinson's disease. In Neurodegeneration: the molecular pathology of dementia and movement disorders, ed. D. W. Dickson, pp. 159–187. Basel: ISN Neuropath Press
Kato, S. & Nakamura, H. (1990). Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol, 79, 584–94CrossRefGoogle ScholarPubMed
Koller, W. C. (1992). When does Parkinson's disease begin?Neurology 42(4 Suppl 4), 27–31Google ScholarPubMed
Kosaka, K. (1990). Diffuse Lewy body disease in Japan. J. Neuro.. 237, 197–204CrossRefGoogle ScholarPubMed
Kosaka, K., Yoshimura, M., Ikeda, K. & Budka, H. (1984). Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree – a new disease?Clin. Neuropathol., 3, 185–92Google ScholarPubMed
Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. & Ihara, Y. (1988). Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol., 75, 345–53CrossRefGoogle ScholarPubMed
Lantos, P. L. (1998). The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol., 57, 1099–111CrossRefGoogle ScholarPubMed
Lennox, G., Lowe, J. S., Landon, M., Byrne, E. J., Mayer, R. J. & Godwin-Austen, R. B. (1989). Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg., Psychiatr., 52, 1236–47CrossRefGoogle ScholarPubMed
Lippa, C. F., Fujiwara, H., Mann, D. M. A.et al. (1998). Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol., 153, 1365–70CrossRefGoogle ScholarPubMed
Masliah, E., Galasko, D., Wiley, C. A. & Hansen, L. A. (1990). Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol., 80, 453–8CrossRefGoogle Scholar
Mattila, P. M., Roytta, M., Torikka, H., Dickson, D. W. & Rinne, J. O. (1998). Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol., 95, 576–82CrossRefGoogle ScholarPubMed
McGreer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. (1998). Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology, 38, 1285–91CrossRefGoogle Scholar
McGreer, P.L. & McGeer, E. G. (2001). Inflammation in Parkinson's disease. Adv. Neurol., 86, 83–9Google Scholar
McKeith, I. G., Galasko, D., Kosaka, K.et al. (1996). Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on Dementia with Lewy Bodies International Workshop. Neurology, 47, 1113–24CrossRefGoogle Scholar
Neumann, M., Kahle, P. J., Giasson, B. I.et al. (2002). Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J. Clin. Invest., 110, 1429–39CrossRefGoogle ScholarPubMed
Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R. & Leurgans, S. (1999). Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov. Disord., 14, 117–213.0.CO;2-0>CrossRefGoogle ScholarPubMed
Parkkinen, L., Soininen, H. & Alafuzoff, I. (2003). Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J. Neuropathol. Exp. Neurol., 62, 363–7CrossRefGoogle ScholarPubMed
Pollanen, M. S., Bergeron, C. & Weyer, L. (1992). Detergent-insoluble Lewy body fibrils share epitopes with neurofilament and tau. J. Neurochem., 58, 1953–6CrossRefGoogle ScholarPubMed
Pollanen, M. S., Dickson, D. W. & Bergeron, C. (1993). Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol., 52, 183–91CrossRefGoogle ScholarPubMed
Salin-Pascual, R., Gerashchenko, D., Greco, M., Blanco-Centurion, C. & Shiromani, P. J. (2001). Hypothalamic regulation of sleep. Neuropsychopharmacology, 25(5 Suppl), S21–27CrossRefGoogle Scholar
Taki, J., Nakajima, K., Hwang, E. H.et al. (2000). Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur. J. Nucl. Med., 27, 566–73CrossRefGoogle ScholarPubMed
Tsuboi, Y., Iwatsubo, T. & Dickson, D. W. (2003). Striatal α-synuclein burden correlates with disease duration in Parkinson's disease (PD), but not in dementia with Lewy bodies (DLB). Brain Pathol., 13, S32Google Scholar
Tu, P. H., Galvin, J. E., Baba, M.et al. (1998). Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol., 44, 415–22CrossRefGoogle ScholarPubMed
Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H. & Takahashi, H. (2000). NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol., 99, 14–20CrossRefGoogle ScholarPubMed
Whitehouse, P. J., Hedreen, J. C., White, C. L. & Price, D. L . (1993). Basal forebrain neurons in dementia of Parkinson disease. Ann. Neurol., 13, 243–8CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×